Supplementary Figure S4 from Mutations in the IFNγ-JAK-STAT Pathway Causing Resistance to Immune Checkpoint Inhibitors in Melanoma Increase Sensitivity to Oncolytic Virus Treatment

Autor: Ian R. Watson, Tommy Alain, Dirk Schadendorf, Mathieu Lajoie, Mozhdeh Ahanfeshar-Adams, LeeAnn Ramsay, Tan-Trieu Nguyen
Rok vydání: 2023
DOI: 10.1158/1078-0432.22479218
Popis: Supp Figure S4. JAK1/2 inhibitor Ruxolitinib increases melanoma sensitivity to VSV-d51
Databáze: OpenAIRE